Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A1 | P30531 | 4/20 | 0.33 |
| ▸ | SLC6A11 | P48066 | 3/20 | 0.33 |
| ▸ | SLC6A13 | Q9NSD5 | 3/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | GABRA5 | P31644 | 2/20 | 0.32 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.32 |
| ▸ | SLC6A12 | P48065 | 2/20 | 0.32 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.32 |
| ▸ | GABRR1 | P24046 | 1/20 | 0.32 |
| ▸ | GABRA4 | P48169 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7587103 | 1.00 | SLC6A1 (0.33) | SLC6A1SLC6A11SLC6A13TSHRLMNA | |
| Hydrochloric Acid SCHEMBL8112201 | 0.98 | SLC6A1 (0.32) | SLC6A1SLC6A11SLC6A13TSHRLMNA | |
| Hydrochloric Acid SCHEMBL7590833 | 0.98 | SLC6A1 (0.32) | SLC6A1SLC6A11SLC6A13TSHRLMNA | |
| SCHEMBL10753923 | 0.81 | — | — | |
| SCHEMBL8103030 | 0.81 | KDM4E (0.35) | — | |
| SCHEMBL1351693 | 0.81 | CHRM2 (0.33) | — | |
| SCHEMBL19209920 | 0.79 | SLC6A1 (0.31) | SLC6A1SLC6A11SLC6A13GABRA5GABRB2 | |
| SCHEMBL31031091 | 0.79 | CHRM2 (0.33) | — | |
| Hydrochloric Acid SCHEMBL28060494 | 0.79 | CHRM2 (0.33) | — | |
| Hydrochloric Acid SCHEMBL27835399 | 0.79 | CHRM2 (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2720744-B1 | AN ANESTHETIC CIRCUIT | DMF MEDICAL INCORPORATED (CA) | 2017-09-06 | — | — | EP | claimed |
| CN-102797043-B | Medicinal molecular fragment library and construction process thereof | Tianli (Tianjin) Technology Co., Ltd. (CN) | 2015-11-25 | — | — | CN | claimed |
| CN-102797043-A | Medicinal molecular fragment library and construction method thereof | CBB NETWORK CO LTD | 2012-11-28 | — | — | CN | claimed |
| EP-1877505-B1 | AMINE- AND PHTHALOCYANINE DYE-CONTAINING INK-JET INKS WITH IMPROVED OZONE FASTNESS | HEWLETT PACKARD DEVELOPMENT CO (US) | 2010-08-04 | — | — | EP | claimed |
| EP-1587795-A1 | N- (1-BENZYL-2-OXO-2- (1-PIPERAZINYL) ETHYL) -1-PIPERIDINCARBOXAMID-DERIVATIVES AND RELATED COMPOUNDS USE AS CGRP-ANTAGONISTS FOR TREATING A HEADACHE | Boehringer Ingelheim International GmbH (DE) | 2005-10-26 | — | — | EP | claimed |
| EP-1529247-A1 | USE OF SALTS OF LAYERED DOUBLE HYDROXIDES | Clariant GmbH (DE) | 2005-05-11 | — | — | EP | claimed |
| WO-2004063171-A1 | N- (1-BENZYL-2-OXO-2- (1-PIPERAZINYL) ETHYL) -1-PIPERIDINCARBOXAMID-DERIVATIVES AND RELATED COMPOUNDS USE AS CGRP-ANTAGONISTS FOR TREATING A HEADACHE | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2004-07-29 | — | — | WO | claimed |
| WO-2004019138-A1 | USE OF SALTS OF LAYERED DOUBLE HYDROXIDES | CLARIANT GMBH (DE) | 2004-03-04 | — | — | WO | claimed |
| EP-0756593-B1 | PROCESS FOR PREPARING 2-PIPERAZINE CARBOXYLIC ACID DERIVATIVES | LONZA AG (CH) | 2000-09-20 | — | — | EP | claimed |
| EP-0756593-A1 | PROCESS FOR PREPARING 2-PIPERAZINE CARBOXYLIC ACID DERIVATIVES | LONZA AG (CH) | 1997-02-05 | — | — | EP | claimed |
| WO-1995029169-A2 | PROCESS FOR PREPARING 2-PIPERAZINE CARBOXYLIC ACID DERIVATIVES | LONZA AG (CH) | 1995-11-02 | — | — | WO | claimed |
| EP-0159889-B1 | 4-SUBSTITUTED PIPERAZINE-2-CARBOXYLIC ACIDS PROCESS AND PHARMACEUTICAL COMPOSITIONS | BTG INTERNATIONAL LIMITED (GB) | 1992-09-30 | — | — | EP | claimed |
| CN-102797043-B | Medicinal molecular fragment library and construction process thereof | Tianli (Tianjin) Technology Co., Ltd. (CN) | 2015-11-25 | — | — | CN | disclosed |
| CN-102797043-A | Medicinal molecular fragment library and construction method thereof | CBB NETWORK CO LTD | 2012-11-28 | — | — | CN | disclosed |
| EP-1587795-A1 | N- (1-BENZYL-2-OXO-2- (1-PIPERAZINYL) ETHYL) -1-PIPERIDINCARBOXAMID-DERIVATIVES AND RELATED COMPOUNDS USE AS CGRP-ANTAGONISTS FOR TREATING A HEADACHE | Boehringer Ingelheim International GmbH (DE) | 2005-10-26 | — | — | EP | disclosed |
| EP-1529247-A1 | USE OF SALTS OF LAYERED DOUBLE HYDROXIDES | Clariant GmbH (DE) | 2005-05-11 | — | — | EP | disclosed |
| EP-0796271-A1 | NEW DIPEPTIDE P-AMIDINOBENZYLAMIDES WITH N-TERMINAL SULFONYL OR AMINOSULFONYL RADICALS | BASF AKTIENGESELLSCHAFT (DE) | 1997-09-24 | — | — | EP | disclosed |
| EP-0756593-A1 | PROCESS FOR PREPARING 2-PIPERAZINE CARBOXYLIC ACID DERIVATIVES | LONZA AG (CH) | 1997-02-05 | — | — | EP | disclosed |
| WO-1996017860-A1 | NEW DIPEPTIDE P-AMIDINOBENZYLAMIDES WITH N-TERMINAL SULFONYL OR AMINOSULFONYL RADICALS | BASF AKTIENGESELLSCHAFT (DE) | 1996-06-13 | — | — | WO | disclosed |
| WO-1995029169-A2 | PROCESS FOR PREPARING 2-PIPERAZINE CARBOXYLIC ACID DERIVATIVES | LONZA AG (CH) | 1995-11-02 | — | — | WO | disclosed |